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node homing receptors into a central memory CD8
T cell (TCM) subset (CD45RACD62LCCR7CD27CD28
IFN perforin) and two effector memory CD8 T cellSummary
(TEM) populations, both lacking lymph node homing re-
ceptors (CD45RACD62LCCR7 and CD45RACD62LWhy HIV-specific CD8 T cells ultimately fail to clear or
control HIV infection is not known. We show here that CCR7) (Sallusto et al., 1999; Tussey et al., 2000). Al-
though HIV-specific CD8 T cells express a memoryHIV-specific CD8 T cells exhibit increased sensitivity to
CD95/Fas-induced apoptosis. This apoptosis is 3-fold phenotype using the CD45RO marker (Altman et al.,
1996; Appay et al., 2000), it is unclear whether theyhigher compared to CMV-specific CD8 T cells from the
same patients. HIV-specific CD8 T cells express the belong to the TCM or to one of the TEM populations. Such
characterization of HIV-specific CD8 T cells may yieldCD45RACD62L but lack the CD45RACD62L T cell
effector memory (TEM) phenotype. This skewing is not invaluable information as to the effector function and
homing properties of these cells.found in CMV- and EBV-specific CD8 T cells in HIV-
infected individuals. CD95/Fas-induced apoptosis is The aim of the current study was to examine HIV-
specific, CMV-specific, and EBV-specific CD8 T cellsmuch higher in the CD45RACD62L TEM cells. How-
ever, cytotoxicity and IFN production by HIV-specific from freshly isolated peripheral blood mononuclear cells
of HIV-infected individuals and to determine whetherCD8 T cells is not impaired. Our data suggest that
the survival and differentiation of HIV-specific CD8 there are differences in the memory phenotype and apo-
ptotic potential between these virus-specific popula-T cells may be compromised by CD95/Fas apoptosis
induced by FasL-expressing HIV-infected cells. tions. We find that HIV-specific CD8 T cells are much
more prone to undergo anti-CD95/Fas-induced apopto-
sis compared to CMV-specific CD8 T cells and HIV-Introduction
infected macrophages can induce apoptosis of HIV-
specific CD8 T cells. Additionally, HIV-specific CD8A key role for CD8-mediated immune responses in con-
trolling human immunodeficiency virus (HIV) infection T cells lack the terminally differentiated CD45RACD62L
TEM population that is found in CMV- and EBV-specifichas been suggested by a number of investigators over
the last years (Borrow et al., 1994; Ogg et al., 1998), CD8 T cells and our findings suggest that CD95/Fas-
induced apoptosis may play a role in this. Finally, wehowever the function and phenotype of HIV-specific
CD8 T cells has yet to be fully elucidated. do not find any evidence for impaired cytotoxicity or
IFNproduction by HIV-specific CD8T cells. SensitivityProgrammed cell death (apoptosis) has been pro-
posed as an important contributor to the pathogenesis to anti-CD95/Fas-induced apoptosis is of particular im-
portance as it may impair the capability of HIV-specificof HIV infection and as a mechanism responsible for the
loss of CD4 and CD8 T cells which is observed in HIV CD8 T cells to kill HIV-infected macrophages and CD4
T cells that have upregulated FasL (Badley et al., 1996;infection (Groux et al., 1992; Meyaard et al., 1992). A
number of studies have shown that T cells from HIV- Tateyama et al., 2000), thus resulting in escape of virally
infected cells from the CTL response.infected individuals exhibit increased spontaneous apo-
ptosis (Gougeon et al., 1993; Meyaard et al., 1992), acti-
vation-induced cell death (AICD) (Gougeon et al., 1993; Results
Groux et al., 1992; Katsikis et al., 1996; Meyaard et al.,
1992), and Fas/CD95 mediated apoptosis (Estaquier et HIV-Specific CD8 T Cells Show Increased
al., 1995; Katsikis et al., 1995). Such apoptosis also oc- Susceptibility to Anti-CD95/Fas-Induced Apoptosis
curs in vivo as increased apoptosis of CD8 T cells, To determine whether HIV-specific CD8 T cells differ
CD4 T cells, and B cells has been demonstrated in the in their apoptotic potential when compared to other
lymph nodes of HIV-infected individuals (Bofill et al., virus-specific CD8 T cells, spontaneous apoptosis,
activation-induced cell death (AICD) and anti-CD95/Fas-
induced apoptosis were measured in PBMCs from HIV-5 Correspondence: katsikis@drexel.edu
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Table 1. Apoptosis of Virus-Specific CD8 T Cells in HIV-Infected Individuals
HIV-Specific CMV-Specific Total CD8 T Cells
CD8 T Cells1 CD8 T Cells1 CD8 T Cells1 HIV-Uninfected 2
Treatment: (% Annexin V)
Spontaneous 18  3.8 3 17  3.0 14  1.9 3.5  0.7
Anti-CD3 antibody 30  6.7 24  3.7 25  5.0 4.6  1.0
Anti-CD95 antibody 45  6.6 27  5.7 25  4.7 5.5  1.2
1 n  8 for spontaneous and anti-CD95, n  7 for anti-CD3
2 n  10
3 Mean  SE
infected individuals, which had both HIV- and CMV- duce more HIV-specific CD8 T cell apoptosis (3.6 
2.1%, n  4). However, polystyrene bead-stimulatedspecific CD8 T cells.
Spontaneous cell death in overnight cultures did not HIV-infected macrophages significantly induced apo-
ptosis of HIV-specific CD8 T cells up to 20  2.7%differ between HIV-specific, CMV-specific and total
CD8 T cells (Table 1, Figures 1A and 1B). Anti-CD3- (n  4, P  0.05) (Figure 1D). When a neutralizing anti-
FasL monoclonal antibody was added to these cultures,induced apoptosis was also not different between HIV-
specific, CMV-specific, and total CD8 T cells (Table 1, apoptosis was reduced to 11  1.9% (n  4) (Figure
1D). When treatment-specific apoptosis was calculated,Figures 1A and 1B). When treatment-specific apoptosis
was calculated, AICD did not differ between total CD8 bead-stimulated HIV-infected macrophages induced
apoptosis in 17  3.7% of HIV-specific CD8 T cellsT cells (14  4.9%), HIV-specific (18  6.3%) and CMV-
specific CD8 T cells (11  4.2%) (Figure 1C). Anti-CD3 and this was reduced to 9  2.3% by the anti-FasL
antibody. Anti-FasL antibody reduced specific apo-treatment reduced the live cell numbers of both HIV- and
CMV-specific CD8 T cells in culture (data not shown); ptosis of HIV-specific CD8 T cell induced by HIV-
infected macrophages by 46  12%.however we cannot exclude that this is due to downreg-
ulation of the TCR rather than loss due to death. Isotype The above findings clearly show that HIV-specific
CD8 T cells in HIV-infected individuals are more sus-control antibodies induced no apoptosis.
Susceptibility to CD95/Fas-induced apoptosis was ceptible to anti-CD95-induced apoptosis compared to
CMV-specific CD8T cells; this increased susceptibilitysignificantly increased in HIV-specific CD8 T cells (45
6.6%) compared to CMV-specific (27  5.7%) and total is specific for HIV-specific CD8 T cells and is not a
general feature of virus-specific CD8 T cells in HIV-CD8 T cells (25  4.7%) in HIV-infected individuals
(Table 1, Figures 1A and 1B). This susceptibility was infected individuals. Finally, we show that HIV-infected
macrophages induce CD95/Fas-mediated apoptosis of3-fold higher in HIV-specific compared to CMV-specific
CD8 T cells when specific anti-CD95-induced apo- HIV-specific CD8 T cells.
ptosis was calculated (HIV-specific CD8 T cells: 31 
8.5%, CMV-specific CD8 T cells: 12  5.8%, P  0.05) Phenotype of HIV-, CMV-, and EBV-Specific
CD8 T Cells in HIV-Infected Individuals(Figure 1C). Specific anti-CD95-induced apoptosis for
total CD8 T cells was 12 5.9% (P 0.01) (Figure 1C). In order to phenotypically characterize virus-specific
CD8 T cells in HIV-infected individuals, we usedAnti-CD95 treatment reduced significantly the absolute
numbers of live HIV-specific CD8 T cells in culture CD45RA and the lymph node homing receptor CD62L
to classify cells into naive cells (CD45RACD62L), a(2.5  0.7  103 spontaneous to 1.6  0.6  103 after
anti-CD95 stimulation, P  0.05). In contrast no such central memory population (CD45RACD62L) and two
effector memory populations CD45RACD62L andeffect was seen in the CMV-specific CD8 T cells (3.7
1.5  103 spontaneous to 3.2  1.4  103 after anti- CD45RACD62L as previously described (Roederer et
al., 1995; Sallusto et al., 1999).CD95 stimulation). No apoptosis was induced by isotype
control antibodies. In virus-specific CD8 T cell populations in HIV-
infected individuals, the CD45RACD62L cell andAs mentioned above, FasL is upregulated on HIV-
infected macrophages (Badley et al., 1996; Dockrell et CD45RACD62LTCM population distribution did not dif-
fer between the HIV-, CMV-, and EBV-specific CD8al., 1998). We therefore examined whether HIV-infected
macrophages can also induce CD95/Fas-mediated apo- T cells (Table 2, Figure 2A). However, significantly more
TEM CD45RACD62L cells were found in HIV-specificptosis of HIV-specific CD8 T cells. Since FasL is stored
intracellularly by macrophages, and is expressed on the CD8 T cells (68  3.5%) compared to the other virus-
specific CD8 T cells (43  4.1% and 41  6.3% forsurface or released as soluble FasL when macrophages
are stimulated by phagocytosis (Brown and Savill, 1999; CMV- and EBV-specific CD8T cells respectively) (Table
2, Figures 2A and 2B). The terminally differentiated TEMKiener et al., 1997), we examined HIV-specific CD8
T cell apoptosis after 14 hr incubation with in vitro HIV- CD45RACD62L phenotype was strikingly reduced in
the HIV-specific CD8 T cells (10  2.8%) comparedinfected monocytes that had been stimulated by phago-
cytosis of polystyrene beads (Figure 1D). In the absence with CMV- (31  5.0%) and EBV-specific CD8 T cells
(30  9.5%) (Table 2, Figures 2A and 2B). The differ-of bead stimulation only 3.8  2.0% and 2.4  0.8%
(n 4) of HIV-specific CD8 T cells underwent apoptosis ent distribution of the TEM phenotypes in virus-specific
cells was even more evident when the ratios of theseafter coculture with uninfected macrophages and HIV-
infected macrophages, respectively. Uninfected macro- two subpopulations were compared. The ratio of
CD45RACD62L/CD45RACD62L for HIV-specificphages stimulated with polystyrene beads did not in-
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Figure 1. HIV-Specific CD8 T Cells Are Susceptible to CD95/Fas-Induced Apoptosis
(A) Representative flow cytometry from one patient showing HIV- and CMV-specific CD8 T cell apoptosis.
(B) Frequency of Annexin V cells after no stimulation (n  8) or stimulation with anti-CD3 (n  7) or anti-CD95 (n  8) for total CD8 T cells,
HIV-specific and CMV-specific CD8 T cells shown. Horizontal bars depict medians.
(C) Percentage of specific apoptosis is shown for anti-CD3 induced and anti-CD95 induced apoptosis in total CD8 T cells, HIV-specific and
CMV-specific CD8 T cells. Bars depict mean  SE.
(D) HIV-specific CD8 T cell apoptosis in coculture experiments. Uninfected and HIV-infected autologous macrophages were stimulated with
polystyrene beads and incubated with purified CD8 T cells in the presence or absence of a neutralizing anti-FasL antibody. Facs plots are
gated on HIV-specific CD8 T cells and show apoptosis of these cells. The percentage of Annexin V HIV-specific CD8 T cells is shown in
each plot. A representative experiment of four performed shown.
cells was 17  3.2 compared to a ratio of 3.1  0.8 for was significantly higher compared to the total CD8
T cell population (P  0.05) (Table 2). The expressionCMV-specific and 2.9  0.8% for EBV-specific CD8
T cells (Figure 2C). of the activation markers CD69, CD25, CD38, HLA-DR
and CD57 did not differ significantly between virus-spe-The frequency of CD28CD8 T cells did not differ
between HIV-, CMV-, and EBV-specific CD8 T cells but cific CD8 T cells (Table 2).
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Table 2. Phenotypic Characterization of Virus-Specific CD8 T Cells in HIV-Infected Individuals
HIV-Specific CMV-Specific EBV-Specific Total CD8 T Cells
CD8 T Cells1 CD8 T Cells2 CD8 T Cells3 CD8 T Cells1 HIV-Uninfected4
(%) (%) (%) (%) (%)
CD45RACD62L 5.5  0.8 5 4.8  0.8 9.6  2.7 22  2.5 58  4.7
CD45RACD62L 16  2.5 21  5.1 19  5.6 22  2.5 7.5  2.0
CD45RACD62L 68  3.5 43  4.1 41  6.3 32  2.9 9.5  3.1
CD45RACD62L 10  2.8 31  5.0 30  9.5 21  3.1 26  5.9
CD28 70  5.4 72  4.7 78  8.2 54  5.2 38  8.9
CD69 1.2  0.3 0.5  0.1 ND6 0.9  0.1 ND
CD25 1.4  0.7 1.4  0.6 1.1  0.1 3.2  2.0 0.6  0.1
CD38 22  4.0 30  9.1 37  15 17  3.8 3.5  1.1
HLA-DR 27  7.4 34  6.7 35  13 26  4.8 3.1  0.9
CD57 52  7.8 55  10 34  18 35  6.7 ND
1 n  22 for CD45RA/CD62L, n  9 for all other
2 n  16 for CD45RA/CD62L, n  8 for all other
3 n  9 for CD45RA/CD62L, n  3 for all other
4 n  5
5 Mean  SE
6 ND: Not determined
We then examined whether CD45RACD62L CD8 In summary, in a direct killing assay using purified
CD8 T cells as effector cells and HIV- (Gag- and Pol-)T cells are more sensitive to CD95/Fas-induced apo-
ptosis than the terminally differentiated CD45RACD62L and CMV-peptide loaded C1R-A2 target cells, all virus-
specific CD8 T cells showed effective killing capacityCD8 T cells, as this may have accounted for the differ-
ence in CD95/Fas-induced apoptosis between HIV- and and no evidence of a reduced cytotoxicity of the HIV-
specific CD8 T cells could be demonstrated. HIV-spe-CMV-specific CD8 T cells. CD95/Fas-induced apopto-
sis was increased in both these populations in the HIV- cific and CMV-specific CD8 T cells in HIV-infected indi-
viduals did not differ in their capability to produce IFN,specific compared to the CMV-specific CD8 T cells
(Figures 3A and 3B). Sensitivity however, was higher therefore no impairment in IFN production could be
attributed to HIV-specific CD8 T cells.in the CD45RACD62L population and lower in the
CD45RACD62L cells, while the CD45RACD62L and
the central memory populations were resistant (Figures CD95/Fas-Induced Apoptosis of Virus-Specific
3A and 3B). CD8 T Cells Does Not Correlate with CD95
Expression or HIV Viral Load
To determine whether differences in susceptibility toHIV-Specific CD8 T Cells Do Not Exhibit Impaired
Cytotoxicity or IFN Production CD95/Fas induced apoptosis could be attributed to dif-
ferences in CD95/Fas expression, CD95/Fas expressionPurified CD8 T cells from freshly isolated PBMC were
used in a direct cytotoxicity assay to determine whether was examined on CD8 T cells in HIV-infected and unin-
fected individuals (Figure 5A). In uninfected individualsHIV-specific CD8 T cells differ in their cytotoxic capac-
ity compared to CMV-specific CD8 T cells. In addition, 65  8.1% of CD8 T cells expressed CD95 (n  5),
whereas in HIV-infected individuals 95  0.7% of CD8PBMC of HIV-infected individuals were stimulated with
HIV- or CMV-specific peptides and IFN production was T cells coexpressed CD95 (n  5). No differences in
CD95 expression was found among the memory sub-measured by intracellular staining.
Overall, in nine HIV-infected individuals examined, populations within HIV-, CMV-, and EBV-specific CD8
T cells and between these different virus-specific CD8HIV-specific CD8 T cells did not exhibit a reduced cyto-
toxic potential compared to CMV-specific CD8 T cells. T cells (Figure 5A) as nearly all virus-specific CD8T cells
expressed CD95/Fas. Within HIV-specific memory CD8Both HIV-specific and CMV-specific CD8 T cells were
capable of killing peptide loaded target cells in a direct T cell populations, 100  0.0% of CD45RACD62L
cells, 99 0.5% of CD45RACD62L cells and 92 2.2%ex vivo assay (Figure 4A).
In HIV-infected individuals, HIV-specific tetramer fre- of CD45RACD62L cells were CD95 (n  5); within
the CMV-specific CD8 T cell memory populations,quency was 1.25  0.38% whereas 0.99  0.36% of
CD8 T cells were producing IFN after stimulation with 100  0.0% of CD45RACD62L cells, 100  0.1% of
CD45RACD62L cells and 95  2.2% of CD45RAHIV-specific peptide (n  5). In these same patients the
CMV-specific tetramer frequency was 2.52 1.49% with CD62L cells were CD95 (n  4); and within the CD8
EBV-specific memory population 99 0.50% of CD45RA1.39  0.71% of CD8 T cells producing IFN after
stimulation with CMV-specific peptide (n  5) (Figure CD62L cells, 100  0.0% of CD45RACD62L cells
and 96  2.6% of CD45RACD62L cells were CD954B). The ratio between IFN producing CD8 T cells and
tetramer-positive CD8 T cells was 0.78  0.09 for HIV- (n  3). The mean fluorescence intensity (MFI) was not
different between virus-specific populations.specific CD8 T cells and 0.67  0.07 for CMV-specific
CD8 T cells, respectively. The HIV viral load in HIV-infected individuals may influ-
Apoptosis of HIV-Specific CD8 T Cells
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Figure 2. HIV-Specific CD8 T Cells Lack Terminal Differentiation
(A) The memory phenotype of CD8 T cells, HIV-, CMV-, and EBV-specific CD8 T cells from representative HIV-infected patients is shown.
(B) Pooled data showing the memory distribution of HIV-specific (n  22), CMV-specific (n  16) and EBV-specific (n  9) CD8 T cells. Bars
depict mean  SE.
(C) The ratio of the CD45RACD62L/CD45RACD62L effector memory phenotypes for HIV-specific, CMV-specific and EBV-specific CD8
T cells shown. Bars depict mean  SE.
ence the distribution of memory subpopulations in HIV- Therefore it is unlikely that differences in apoptosis and
phenotype between HIV-, CMV-, and EBV-specific CD8specific CD8 T cells as well as the susceptibility of these
cells to CD95/Fas-induced apoptosis. We therefore exam- T cells are due to much higher HIV viral loads compared
to CMV and EBV viral loads in the patients.ined whether HIV viral load correlated with the skewing
of phenotype and CD95/Fas-induced apoptosis in HIV-
specific CD8 T cells. No correlation was found between Discussion
the ratio of CD45RACD62L/CD45RACD62Lpopula-
tions in HIV-specific CD8 T cells and HIV plasma viral In this study we examined the susceptibility to spontane-
ous, anti-CD3- and anti-CD95-induced apoptosis andload (n 13, RS 0.12) (Figure 5B). CD95/Fas-induced
apoptosis of HIV-specific CD8 T cells also did not cor- characterized the memory phenotype of HIV-, CMV-,
and EBV-specific CD8T cells from HIV-infected individ-relate with plasma viral load in HIV-infected patients
(n  8, RS  0.37) (Figure 5C). uals. We report here that HIV-specific CD8 T cells are
3-fold more prone to CD95/Fas-induced apoptosis com-In conclusion, susceptibility to CD95/Fas-induced
apoptosis and memory phenotype skewing of HIV-spe- pared to CMV-specific CD8 T cells in HIV-infected indi-
viduals. Such susceptibility may seriously compromisecific CD8 T cells did not correlate with HIV viral load.
Immunity
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Figure 3. HIV-Specific Preterminally Differentiated CD45RACD62L TEM CD8 T Cells Are Primed to Undergo Anti-CD95 Induced Apoptosis
(A) Spontaneous and anti-CD95 induced apoptosis of memory populations of HIV Pol-specific (top six panels) and CMV-specific CD8 T cells
(bottom six panels) from one representative experiment of five performed shown. Frequency of Annexin V cells shown.
(B) Pooled data showing spontaneous and anti-CD95 induced apoptosis of memory populations for HIV-specific and CMV-specific CD8
T cells (n  5). Bars depict mean  SE.
the effectiveness of HIV-specific CD8 T cells to clear this apoptosis is at least partially mediated via CD95/
Fas-FasL interactions. FasL upregulation on HIV-infectedinfected cells as HIV-specific CD8 T cells would die
upon contact with FasL expressing HIV-infected macro- cells is mediated by the nef viral protein (Xu et al., 1999)
and nef also inhibits Fas mediated apoptosis of HIVphages (Badley et al., 1996; Dockrell et al., 1998). Indeed,
we show here that HIV-infected macrophages can in- infected cells by inhibiting apoptosis signaling kinase 1
(ASK-1) (Geleziunas et al., 2001). In SIV-infected mon-duce apoptosis of HIV-specific CD8 T cells and that
Apoptosis of HIV-Specific CD8 T Cells
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Figure 4. Cytotoxicity and IFN Production by HIV-Specific CD8 T Cells Is Not Impaired
(A) Cytotoxicity by purified CD8 T cells from patients with HIV-specific (n  9) and CMV-specific (n  7) CD8 T cells shown. An E:T ratio
of 50:1 is shown.
(B) IFN production following virus-specific peptide stimulation. Gag tetramer stain and IFN production shown in top panels, CMV tetramer
stain and IFN production shown in bottom panels. Representative flow cytometry from five performed shown.
keys, SIV-specific CD8 T cells cannot clear the virus anti-CD95/Fas antibody. A number of technical reasons,
however, could be responsible for this difference. Theand this correlates with FasL upregulation by nef (Xu et
al., 1997). Most importantly, blocking Fas/FasL interac- numbers of macrophages in cultures (plates were not
confluent), the ratio of monocytes to CD8 T cells used,tions allows SIV-specific CD8 T cell responses to re-
generate, suggesting an active role of FasL in deleting the percentage of macrophages infected, to mention
just a few, could all influence the amount of apoptosis.SIV-specific CD8 T cells. Our data showing increased
CD95/Fas sensitivity in HIV-specific CD8 T cells indi- Another explanation however, may lie in the ability of
macrophages to phagocytose apoptotic cells very effi-cates that a similar mechanism may be operative in HIV-
infection. Such a mechanism would seriously compro- ciently and very rapidly (Fadok et al., 1992). Finally,
blocking of CD95/Fas-FasL interaction inhibited themise the effectiveness of HIV-specific CD8 T cells to
function as serial killers as they would be receiving a specific macrophage-induced apoptosis of HIV-specific
CD8 T cells by 46  12%. This suggests CD95/Fas-lethal hit themselves upon contact with a FasL express-
ing HIV-infected target. Supporting this is the observa- FasL interactions are a main mechanism for the ob-
served apoptosis. Although the lack of completetion of a rapid death of adoptively transferred autolo-
gous HIV-specific CD8 T cells despite of homing into blocking may be due to insufficient concentrations of
the neutralizing anti-FasL antibody, we cannot excludethe lymph nodes (Brodie et al., 1999, 2000; Tan et al.,
1999). at the moment that additional mechanisms may be in-
volved in the apoptosis of HIV-specific CD8 T cells,As mentioned above, we found that coculture of puri-
fied CD8 T cells with HIV-infected macrophages in- which is induced by HIV-infected macrophages.
The difference in CD95/Fas-induced apoptosis ob-duced apoptosis of HIV-specific CD8 T cells. We found
that apoptosis could only be observed when HIV-infected served between HIV- and CMV-specific CD8 T cells
could not be attributed to different levels in the expres-macrophages were triggered by phagocytosis. This is
in agreement with previous reports showing that phago- sion of CD95 on these cells since virtually all virus-
specific CD8 T cells expressed CD95/Fas. Similar re-cytosis stimulates surface expression and the release
of FasL by macrophages, which store large amounts of sults have been reported for SIV-specific CD8 T cells,
which also all express CD95/Fas (Kuroda et al., 1999).FasL intracellularly (Brown and Savill, 1999; Kiener et
al., 1997). In contrast to polystyrene bead phagocytosis, Whether this high positivity for CD95/Fas is a feature
of all virus-specific CD8 T cells, is acquired duringlipopolysaccharide (LPS) stimulation of HIV-infected
macrophages did not induce any killing of Jurkat cells differentiation, or is the result of continuous antigen
stimulation, is unknown. Our findings indicate thatin our hands (data not shown).This is in agreement with
previous studies that have shown that LPS activation CD95/Fas signaling, and not surface expression, under-
lies the differences between HIV- and CMV-specificdoes not induce FasL in macrophages (Perlman et al.,
2001). The amount of apoptosis we observed in these CD8 T cells in terms of susceptibility to CD95/Fas-
induced apoptosis.experiments was lower than that seen when HIV-specific
CD8 T cells were stimulated directly with immobilized If susceptibility of virus-specific CD8 T cells to CD95/
Immunity
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Figure 5. CD95/Fas Expression Does Not Differ between Virus-Specific CD8 T Cells; HIV Viral Load Does Not Correlate with CD95/Fas-
Induced Apoptosis or the Ratio of Effector Memory Populations in HIV-Specific CD8 T Cells
(A) First row depicts CD95/Fas expression on CD8 T cells from a representative HIV negative and an HIV-infected individual. Rows below
show CD95/Fas expression on the memory subpopulations of HIV-, CMV-, and EBV-specific CD8 T cells from one representative HIV-infected
individual. The percentage depicts CD95/Fas positive cells.
(B) The correlation between the ratio of CD45RACD62L/CD45RACD62L memory HIV-specific CD8 T cells and plasma HIV viral load in
13 HIV-infected individuals is shown. RS  0.12.
(C) The correlation between the percentage of apoptotic HIV-specific CD8 T cells induced by anti-CD95/Fas and plasma HIV viral load in
eight HIV-infected individuals is shown. RS  0.37.
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Fas-induced apoptosis was influenced by viral loads as T cells cannot home to the lymph nodes but preferen-
tially localize to blood and spleen (Tang et al., 1998),a result of chronic antigen stimulation, differences in the
viral loads of HIV and CMV in the blood of HIV-infected the CD45RACD62LSIV-specific CD8 T cells present
in the lymph nodes may be recently generated effectorindividuals may have accounted for the differences in
susceptibility to CD95/Fas apoptosis we found between memory cells rather than re-circulating ones. The lack
of CD62L on both HIV and SIV-specific CD8T cells mayHIV- and CMV-specific CD8 T cells. We believe that
this is unlikely however, as we found no correlation be- thus result in a relatively inefficient homing of these cells
back into the lymph nodes where virus infected cellstween HIV viral load and the susceptibility of HIV-spe-
cific CD8 T cells to CD95-induced apoptosis. We do reside. Evidence for such a lack of homing to lymph
nodes has been previously provided for primary HIVnot believe therefore that different levels of viral loads
between HIV and CMV can account for the difference infection (Pantaleo et al., 1997).
The lack of the terminally differentiated CD45RAin apoptosis we find.
Memory CD8 T cells can be classified into three CD62L population in HIV-specific CD8 T cells may
indicate a functional defect for cytotoxicity since thesedistinct populations based on their phenotype, a central
memory population CD45RACCR7CD62LCD28 cells have the highest perforin expression of memory
cells (Hamann et al., 1997; Sallusto et al., 1999). WeIL-2IFN (Hamann et al., 1997; Sallusto et al., 1999;
Tussey et al., 2000) and two effector memory popula- used highly purified CD8 T cells from freshly isolated
PBMC as effectors to examine cytotoxicity against pep-tions, the CD45RACD62LCCR7 and the terminally
differentiated CD45RACD62LCCR7 populations. These tide loaded C1R-A2 target cells. We found that cytotox-
icity of HIV-specific CD8 T cells was not reduced com-two latter effector memory populations contain perforin,
secrete IFN and TNF, are cytotoxic and are capable pared to CMV-specific CD8 T cells. Our data are in
agreement with Ogg et al. who showed direct ex vivoof rapid effector function after stimulation (Baars et al.,
2000; Hamann et al., 1997; Sallusto et al., 1999; Tussey CTL activity that correlated with the frequency of tetra-
mer positive cells (Ogg et al., 1998). Our findings areet al., 2000). Although a linear differentiation between
these memory populations has been suggested (Sal- however in disagreement with other studies that failed
to show direct ex vivo killing of HIV-specific CD8 T cellslusto et al., 1999), the exact relationship between them
has yet to be fully elucidated. The linear differentiation (Gray et al., 1999; Shankar et al., 2000). A major differ-
ence of these studies from our work was the use ofmodel was recently challenged as it was shown that
of the two effector memory CD8 T cell populations, EBV- transformed cell lines as targets for the cytotoxicity
assay. Since EBV transformation can upregulate FasLCD45RACD62L cells have the capacity to differentiate
into a number of other memory populations, whereas expression on B cells (Tanner and Alfieri, 1999), and as
we show here, HIV-specific CD8 T cells are sensitivethe CD45RACD62L population cannot differentiate
further indicating that this population is truly terminally to CD95/Fas-induced apoptosis, the cytotoxic activity
of HIV-specific CD8 T cells in such an assay would bedifferentiated (Champagne et al., 2001).
The vast majority of HIV-specific CD8 T cells had the greatly underestimated, as these cells would die upon
interaction with a FasL expressing target cell. In theTEM CD45RACD62L phenotype while few cells had the
terminally differentiated CD45RACD62L TEM pheno- cytotoxicity assay we employed, the C1R-A2 target cells
do not express FasL (Y.M. and P.K., our unpublishedtype. This was in contrast to CMV- and EBV-specific
CD8 T cells, which were distributed between the above observations), and therefore would not affect the HIV-
specific CD8 T cell effectors. Another major differencetwo TEM phenotypes. HIV-, CMV-, and EBV-specific
CD8 T cells did not differ in their CD45RACD62L from the previous studies is that we use purified CD8
T cells instead of PBMC as effector cells in our cytotoxic-and TCM phenotype distribution. HIV-, CMV-, and EBV-
specific CD8 T cells were primarily CD28 indicating ity assays. Finally, we did not find a discrepancy be-
tween HIV- and CMV-specific CD8T cells in referencethat they had had multiple antigen-specific contacts
(Effros et al., 1996). The differences in memory pheno- to the frequency of tetramer staining cells and the fre-
quency of IFN producing CD8 T cells following pep-type of virus-specific cells could not be attributed to
differences in their activation status as no differences tide stimulation. This is in agreement with similar find-
ings previously reported by Appay et al. (2000), who alsoin CD69, CD25, HLA-DR, CD38, and CD57 expression
was found. found no impairment of IFN production by HIV-specific
CD8 T cells. Therefore, we could not demonstrate aA similar lack of terminally differentiated TEM cells for
HIV-specific CD8 T cells was recently described using functional impairment of HIV-specific CD8 T cells in
terms of cytotoxicity and IFN production as they didCD45RA and the CCR7 chemokine receptor (Cham-
pagne et al., 2001), and it was attributed to a blockade not differ from CMV-specific CD8T cells in HIV-infected
individuals.of HIV-specific CD8 T cell differentiation. Our findings
complement the above study and also show that HIV- Our findings also point to a mechanism for the lack
of terminally differentiated HIV-specific CD8 T cells inspecific CD8 T cells are not terminally differentiated.
Taken together, the above indicate that HIV-specific CD8 HIV infection. The fact that CMV- and EBV- specific
CD8 T cells in the same patients can differentiate, ex-T cells are CD45RACCR7CD62L preterminally differ-
entiated effector CTLs. Our findings are not likely the cludes this being a nonspecific feature of HIV infection
such as the cytokine milieu or generalized immune acti-results of a bias due to examining peripheral blood and
not lymph nodes as studies in SIV infection have also vation. Soluble HIV proteins such as gp120 and Tat that
can prime T cells for apoptosis (Banda et al., 1992;shown that SIV-specific CD8 T cells are CD45RA
CD62L in both peripheral blood and lymph nodes Katsikis et al., 1997; Li et al., 1995) also can not account
for the selective priming of HIV-specific CD8 T cells(Kuroda et al., 1999, 2000). Since CD62L deficient CD8
Immunity
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Board approval and obtaining informed consent. HLA-A2 and tetra-but not of other virus-specific cells in the same patients.
mer positive HIV-infected individuals were included in this study.The differentiation of CD45RACCR7CD62L into
All individuals were HIV positive since at least one year (range 1–21CD45RACCR7CD62LCD8 T cells requires antigen
years), the median CD4 count was 322 cells/	l (range 18–620), the
stimulation (Champagne et al., 2001; Sallusto et al., median viral load was 1422 RNA copies /ml blood (range 36–
750,000),
1999) and Champagne et al. (2001) demonstrated that all but four received antiviral treatment, nineteen were asymptom-
CD45RACCR7 HIV-specific CD8 T cells could differ- atic, six were symptomatic and none of them had active CMV or
EBV infection. Control samples were collected from age matchedentiate into the terminally differentiated CD45RA
HIV seronegative healthy individuals. HIV viral loads in HIV-infectedCCR7 when these cells are stimulated with peptide
individuals were determined using the Amplicor HIV-1 monitor testand IL-2 in vitro. The question arises why this does
(Roche Diagnostics Corporation, Indianapolis, Indiana).
not occur in vivo. The differences in effector memory
phenotype we found between HIV-specific CD8 T cells Flow Cytometry
and CMV- and EBV-specific CD8 T cells may have Peripheral blood mononuclear cells (PBMC) were freshly isolated
by Ficoll-Hypaque (Amersham Pharmacia Biotech, Sweden) frombeen the result of different levels of chronic antigen
heparinized venous blood of HIV-infected individuals and controls.stimulation due to different viral loads. We have ruled
For rapid identification of HLA-A2 positive individuals by flow cytom-out this possibility however, since we show that the ratio
etry, biotinylated anti-A2/A28 and anti-A2 monoclonal antibodiesof CD45RACD62L/CD45RACD62L effector mem-
(OneLambda, Canoga Park, California) were used. HIV-specific,
ory populations in HIV-specific CD8 T cells does not CMV-specific, and EBV-specific CD8 T cells were identified using
correlate with HIV viral load in HIV-infected individuals. tetramers of HLA class I A*0201-2-microglobulin loaded with Gag
Therefore we believe that viral load does not play a role p17 77–85 (SLYNTVATL) peptide, Pol 476–484 (ILKEPVHGV)
peptide, EBV 280-8 (GLCTLVAML) peptide or CMV p65 495–503in the skewed phenotype of HIV-specific CD8 T cells.
(NLVPMVATV) peptide as previously described (Altman et al., 1996).Based on our findings that show that CD45RA
The following combinations of monoclonal antibodies together withCD62L HIV-specific CD8 T cells are prone to undergo
each of the above APC-labeled tetramers were used to phenotypi-
CD95/Fas-induced apoptosis we propose that when cally characterize virus-specific cells: anti-CD25-FITC/anti-CD28-
these cells interact in vivo with FasL expressing HIV PE/anti-CD8-Cy-Chrome, anti-CD38-FITC/anti-HLA-DR-PE/anti-CD8-
infected cells (Badley et al., 1996; Dockrell et al., 1998), Cy-Chrome, anti-CD45RA-FITC/anti-CD62L-PE/anti-CD8-Cy-Chrome,
in addition to a differentiation signal they also receive anti-CD57-PE/anti-CD8-Cy-Chrome, and anti-CD45RA-FITC/anti-
CD95-PE/ anti-CD62L-Cy-Chrome (PharMingen, San Diego, Cali-a lethal hit and are deleted. Since CD45RACD62LHIV-
fornia).specific CD8 T cells were also sensitive to CD95/Fas-
Briefly, 106 cells were stained with combinations of antibodiesinduced apoptosis, the survival of these cells may also
and tetramers in Hanks Buffered Saline Solution (HBSS, Cellgro,
be affected. Our observations that show that CD45RA Herndon, Virginia), 3% fetal bovine serum (FBS), 0,02% NaN3 for 30
CD62L and CD45RACD62L CMV- and EBV-specific min on ice, washed  2 with HBSS, 3% FBS, 0,02% NaN3 and fixed
CD8 T cells are not primed to undergo Fas-induced with 1% Paraformaldehyde. Analysis was performed on a FACS-
Calibur (Becton Dickinson, San Jose, California) using FlowJo soft-apoptosis suggest that the priming mechanism is an
ware (TreeStar, San Carlos, California).antigen specific one. Such a mechanism could be the
For apoptosis measurement, cells were stained with APC-labeledinteraction of HIV-specific CD8 T cells with HIV-
tetramer and Annexin V-FITC (kind gift from Dr. J. Tait, University ofinfected cells that express envelope proteins (Vlahakis
Washington, Seattle, Washington)/anti-CD28-PE/anti-CD8-Cy-Chrome
et al., 2001) or the lack of HIV-specific CD4 T cell help or Annexin V-FITC/anti-CD62L-PE/anti-CD45RA-Cy-Chrome. When
(Matloubian et al., 1994; Rosenberg et al., 2000; Rosen- Annexin V staining was performed, 25 mM CaCl2 was included in
berg et al., 1997) during the generation and maturation all steps.
of these cells from TCM CD45RACCR7 CD62L cells.
Apoptosis StudiesIn conclusion, we show that HIV-specific CD8 T cells
Freshly isolated PBMC from HIV-infected individuals and controlsare not terminally differentiated effectors compared to
were cultured in RPMI 1640 supplemented with 10% heat-inacti-other virus-specific CD8 T cells in HIV-infected individ-
vated FBS, 2 mM L-Glutamine, 100 U/ml Penicillin and 100 	g/ml
uals. HIV-specific CD8 T cells are not impaired in cyto- Streptomycin-sulfate (Cellgro) for 14 hr at 37C in a 5% CO2 incuba-
toxic function and IFN production but display a higher tor at 1  106 cells/ml/well in 24-well plates coated with or without
sensitivity to anti-CD95 induced apoptosis. In addition, 5 	g/ml monoclonal anti-CD95 antibody (IgM, CH11, Immunotech,
Brea, California), 1 and 10	g/ml anti-CD3 antibody (OKT3) or isotypeHIV-infected macrophages can kill HIV-specific CD8
controls (anti-TNP IgG1 and IgM, PharMingen) as previously de-T cells. Our findings point to a potential functional defect
scribed (Katsikis et al., 1995). Cells stimulated with anti-CD3 anti-of HIV-specific CD8 T cells. Taken together with the
bodies were transferred after 2 hr of incubation to uncoated platesrecent data from Champagne et al. (2001), our findings
for an additional 12 hr to allow the surface reappearance of the
indicate that HIV-specific CD8 T cells have a CD45RA TCR/CD3 complex and permit tetramer staining. Fourteen hours
CD62LCCR7phenotype, which may result in a relative after stimulation cells were harvested and stained for apoptosis.
inefficient homing of these cells into the lymph nodes Specific apoptosis was calculated using the formula:
where virus infected cells reside. Finally, serial killing
by HIV-specific effector CD8 T cells, as well as their (% induced apoptosis % spontaneous apoptosis)
(100  % spontaneous apoptosis)
 100
differentiation and survival, is most likely compromised
due to CD95/Fas sensitivity of these cells. Strategies Macrophage-Induced Apoptosis
promoting the differentiation and abrogating CD95/Fas Monocytes were purified from freshly isolated PBMC by negative
sensitivity of HIV-specific CD8 T cells may enhance selection using RosetteSep human monocyte enrichment cocktail
(StemCell Technologies, Vancouver, Canada). Purity was 
85%viral clearance by these cells.
CD14 cells by flow cytometry. Cells were cultured with 10 ng/ml
M-CSF (R&D systems, Minneapolis, Minnesota) in RPMI/10% FBSExperimental Procedures
in a 24-well plate at 0.5 106 monocytes/0.5ml/well. On day 7, HIV-1
virus (SF162, kind gift from Dr. J. Rappaport, Temple University,Patients
Philadelphia, Pennsylvania) was added at 41ng p24/well (multiplicityPeripheral blood was obtained from 25 HIV seropositive adult pa-
tients following MCP Hahnemann University Institutional Review of infection 0.1). On day 7 postinfection, macrophages were incu-
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bated with 0.5 106 polystyrene latex beads (IDC Spheres, Portland, M.R., and Paya, C.V. (1996). Upregulation of Fas ligand expression
by human immunodeficiency virus in human macrophages mediatesOregon) for 3h at 37C in a 5% CO2 incubator. In some cultures,
20 	g/ml of neutralizing anti-FasL monoclonal antibody (NOK-1, apoptosis of uninfected T lymphocytes. J. Virol. 70, 199–206.
eBioscience, San Diego, California) was added for 90 min before Banda, N.K., Bernier, J., Kurahara, D.K., Kurrle, R., Haigwood, N.,
0.5 106 autologous purified CD8 T cells were added. CD8 T cells Sekaly, R.P., and Finkel, T.H. (1992). Crosslinking CD4 by human
were isolated by negative selection from freshly isolated PBMC immunodeficiency virus gp120 primes T cells for activation-induced
using RosetteSep for CD8 enrichment (StemCell Technologies). apoptosis. J. Exp. Med. 176, 1099–1106.
Purity was 
92% CD8 T cells by flow cytometry with the contami-
Bofill, M., Gombert, W., Borthwick, N.J., Akbar, A.N., McLaughlin,
nating population being CD3CD4 CD8  CD56. After 14 hr incu-
J.E., Lee, C.A., Johnson, M.A., Pinching, A.J., and Janossy, G. (1995).
bation, cells were harvested and stained with Annexin V-FITC/anti-
Presence of CD3CD8Bcl2. (low) lymphocytes undergoing apo-
CD16-PE/anti-CD8-Cy-Chrome/Gag or Pol tetramer-APC. Analysis
ptosis and activated macrophages in lymph nodes of HIV-1 pa-
was performed on a FACS-Calibur (Becton Dickinson) using FlowJo
tients. Am. J. Pathol. 146, 1542–1555.
software (TreeStar).
Borrow, P., Lewicki, H., Hahn, B.H., Shaw, G.M., and Oldstone,
M.B. (1994). Virus-specific CD8 cytotoxic T lymphocyte activityCytotoxicity Assay
associated with control of viremia in primary human immunodefi-CTL activity was determined using the HLA-A2-transfected cell line
ciency virus type 1 infection. J. Virol. 68, 6103–6110.C1R-A2 (HmyC1R-A*201) (kind gift from Dr. J. Frelinger, University
Brodie, S.J., Lewinsohn, D.A., Patterson, B.K., Jiyamapa, D., Krieger,of North Carolina, Chapel Hill, North Carolina) as targets. Briefly,
J., Corey, L., Greenberg, P.D., and Riddell, S.R. (1999). In vivo migra-C1R-A2 were loaded with peptide (Gag p17 77–85, Pol 476–484,
tion and function of transferred HIV-1-specific cytotoxic T cells. Nat.CMV p65 495–503 or EBV 280–288) overnight at 37C in a 5% CO2
Med. 5, 34–41.incubator and then radiolabeled with Na51CrO4 (NEN, Boston, Mas-
sachusetts) for 75 min at 37C. Purified CD8 T cells (see above) Brodie, S.J., Patterson, B.K., Lewinsohn, D.A., Diem, K., Spach, D.,
were incubated with 5 103 C1R-A2 target cells in 96-well U-bottom Greenberg, P.D., Riddell, S.R., and Corey, L. (2000). HIV-specific
plates at an effector/target ratio of 50:1 for 6 hr at 37C. Plates were cytotoxic T lymphocytes traffic to lymph nodes and localize at sites
then centrifuged and 30 	l of supernatants were transferred to 96- of HIV replication and cell death. J. Clin. Invest. 105, 1407–1417.
well LumaPlates (Packard, Meriden, Connecticut) and counted in a Brown, S.B., and Savill, J. (1999). Phagocytosis triggers macrophage
TopCount microplate scintillation counter (Packard). Specific cyto- release of Fas ligand and induces apoptosis of bystander leuko-
toxicity was determined using the formula: cytes. J. Immunol. 162, 480–485.
Champagne, P., Ogg, G.S., King, A.S., Knabenhans, C., Ellefsen, K.,(cpm experimental release cpm spontaneous release)
(cpm maximal release  cpm spontaneous release)
 100 Nobile, M., Appay, V., Rizzardi, G.P., Fleury, S., Lipp, M., et al. (2001).
Skewed maturation of memory HIV-specific CD8 T lymphocytes.
Nature 410, 106–110.Intracellular IFN Staining
Dockrell, D.H., Badley, A.D., Villacian, J.S., Heppelmann, C.J., Alge-PBMC of HIV-infected individuals were stimulated for 6 hr with virus-
ciras, A., Ziesmer, S., Yagita, H., Lynch, D.H., Roche, P.C., Leibson,specific peptide (Gag p17 77–85, CMV p65 495–503) in the present
P.J., and Paya, C.V. (1998). The expression of Fas Ligand by macro-of Brefeldin A (PharMingen). Cells were permeabilized using Cytofix/
phages and its upregulation by human immunodeficiency virus in-Cytoperm (PharMingen) and cell surface staining was performed
fection. J. Clin. Invest. 101, 2394–2405.with anti-CD8-APC followed by an intracellular staining with anti-
IFN-FITC (PharMingen). After fixation with 1% Paraformaldehyde, Effros, R.B., Allsopp, R., Chiu, C.P., Hausner, M.A., Hirji, K., Wang,
analysis was performed on a FACS-Calibur (Becton Dickinson) using L., Harley, C.B., Villeponteau, B., West, M.D., and Giorgi, J.V. (1996).
FlowJo software (TreeStar). Shortened telomeres in the expanded CD28–CD8 cell subset in
HIV disease implicate replicative senescence in HIV pathogenesis.
Statistical Analysis Aids 10, F17–22.
Statistical analysis was performed using Mann-Whitney u test, Stu- Estaquier, J., Idziorek, T., Zou, W., Emilie, D., Farber, C.M., Bourez,
dent’s t Test, nonparametric Wilcoxon signed-rank test for paired J.M., and Ameisen, J.C. (1995). T helper type 1/T helper type 2
samples and Shapiro-Wilk w test of normality. P values 0.05 were cytokines and T cell death: preventive effect of interleukin 12 on
considered significant. The JMP statistical analysis program was activation-induced and CD95 (FAS/APO-1)- mediated apoptosis of
used (SAS, Cary, North Carolina). CD4 T cells from human immunodeficiency virus- infected persons.
J. Exp. Med. 182, 1759–1767.
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